Press Releases

Press Releases

    Date Title View
    01/24/20
    Summary ToggleHorizon Therapeutics plc Announces Changes in Research and Development Organization
    PDF Version
    01/22/20
    Summary ToggleThe New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial (OPTIC) of TEPEZZA™ (teprotumumab-trbw) for Thyroid Eye Disease
    PDF Version
    01/21/20
    Summary ToggleFDA Approves TEPEZZA (TM) (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
    PDF Version
    01/13/20
    Summary ToggleHorizon Therapeutics plc Increases Peak U.S. Annual Net Sales Expectations for Key Growth Drivers; Provides Update on Several Pipeline Programs
    PDF Version
    01/13/20
    Summary ToggleMIRROR Open-Label Study Topline Data of Methotrexate with KRYSTEXXA (pegloticase injection) Indicates Significant Improvement in Response Rate
    PDF Version